Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Soleno Therapeutics (SLNO – Research Report) and ...

10 analysts have shared their evaluations of Rhythm Pharmaceuticals (NASDAQ:RYTM) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

H.C. Wainwright raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $70 from $69 and keeps a Buy rating on the shares following the Q4 report. The firm believes the company’s ...

Discover the top 10 most successful logo rebranding examples that transformed brands and boosted presence. See how design makes an impact! That's precisely what these 10 companies did with their logo ...

Handelsbanken Fonder AB lessened its position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 11.9% in the 4th quarter, HoldingsChannel reports. The institutional ...

This page features the latest news about the Rhythm Pharma stock. Citizens JMP maintains Rhythm Pharma Outperform, $81 target On Thursday, Citizens JMP reiterated its Market Outperform rating on ...